Patient was transferred to ICU, intubated, and started on DKA protocol and hemodialysis.  On Day 2 of admission, the patient developed cardiogenic shock resistant to inotropes.  Patient was started on beta-blockers and ACE inhibitor, extubated and fitted with a wearable life vest/ defibrillator. 1-month Follow-up Troponin was 0.02 ng/ml, ECG normalized, and echo showed improved EF and ventricular motion. The gene discussed is ACE; the disease is Shock.